Mahamaya Lifesciences Limited (BOM:544611)
186.00
-2.00 (-1.06%)
At close: Aug 14, 2026
Mahamaya Lifesciences Market Cap
Mahamaya Lifesciences has a market cap or net worth of 4.35 billion as of August 14, 2026.
Market Cap
4.35B
Enterprise Value
4.87B
Revenue
3.29B
Ranking
n/a
PE Ratio
22.33
Stock Price
186.00
ChartMarket Cap Chart
Since November 18, 2025, Mahamaya Lifesciences's market cap has increased from 2.71B to 4.35B, an increase of 60.34%. That is a compound annual growth rate of 89.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.35B | 0.81% |
| Dec 31, 2025 | 4.32B | 59.05% |
| Nov 18, 2025 | 2.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Southern Petrochemical Industries Corporation | 13.81B |
| Excel Industries | 13.03B |
| 3B Blackbio Dx | 10.47B |
| Advance Agrolife | 7.66B |
| Best Agrolife | 6.71B |
| Aries Agro | 5.03B |
| Khaitan Chemicals and Fertilizers | 4.98B |
| Rama Phosphates | 4.26B |